Citation: | LIANG Yu-jie, CHEN Da-wei, WEN Xiao-rong, et al. Successful Treatment of Refractory Ischemic Diabetic Foot Ulcers by Combination Therapy of Autologous Platelet-rich Gel and Topical β Adrenergic Receptor Blocker: a Case Report[J]. Journal of Sichuan University (Medical Sciences), 2020, 51(4): 582-586. DOI: 10.12182/20200460601 |
[1] |
JIANG Y, WANG X, XIA L, et al. A cohort study of diabetic patients and diabetic foot ulceration patients in China. Wound Repair Regen,2015,23(2): 222–230. DOI: 10.1111/wrr.12263
|
[2] |
XU Z, RAN X. Diabetic foot care in China: challenges and strategy. Lancet Diabetes Endocrinol,2016,4(4): 297–298. DOI: 10.1016/S2213-8587(16)00051-6
|
[3] |
GARIMELLA P S, WANG W, LIN S F, et al. Incident diabetic foot ulcers and mortality in hemodialysis patients. Hemodial Int,2017,21(1): 145–147. DOI: 10.1111/hdi.12490
|
[4] |
AL-THANI H, EL-MENYAR A, KOSHY V, et al. Implications of foot ulceration in hemodialysis patients: a 5-year observational study. J Diabetes Res, 2014, 2014: 945075[2020-03-12]. https://doi.org/10.1155/2014/945075.
|
[5] |
LEV-TOV H, DAHLE S, MOSS J, et al. Successful treatment of a chronic venous leg ulcer using a topical beta-blocker. J Am Acad Dermatol, 2013, 69(4): e204-e205[2020-03-12]. https://doi.org/10.1016/j.jaad.2013.06.003.
|
[6] |
袁南兵, 王椿, 王艳, 等. 自体富血小板凝胶在糖尿病难治性皮肤溃疡中的初步应用. 四川大学学报(医学版),2007,38(5): 900–903.
|
[7] |
THOMAS B, KURIEN J S, JOSE T, et al. Topical timolol promotes healing of chronic leg ulcer. J Vasc Surg Venous Lymphat Disord,2017,5(6): 844–850. DOI: 10.1016/j.jvsv.2017.04.019
|
[8] |
ALSAAD A M S, ALSAAD S M, FATHADDIN A, et al. Topical timolol for vasculitis ulcer: a potential healing approach. JAAD Case Rep,2019,5(9): 812–814. DOI: 10.1016/j.jdcr.2019.07.016
|
[9] |
BRAUN L R, LAMEL S A, RICHMOND N A, et al. Topical timolol for recalcitrant wounds. JAMA Dermatol,2013,149(12): 1400–1402. DOI: 10.1001/jamadermatol.2013.7135
|
[10] |
MOHAMMADI A A, BAKHSHAEEKIA A, ALIBEIGI P, et al. Efficacy of propranolol in wound healing for hospitalized burn patients. J Burn Care Res,2009,30(6): 1013–1017. DOI: 10.1097/BCR.0b013e3181b48600
|
[11] |
中华医学会糖尿病学分会, 中华医学会感染病学分会, 中华医学会组织修复与再生分会. 中国糖尿病足防治指南(2019版)(Ⅳ). 中华糖尿病杂志,2019,11(5): 316–327. DOI: 10.3760/cma.j.issn.1674-5809.2019.05.003
|
[12] |
YANG H, CHEN F, JIAO H, et al. Management of tunneled-cuffed catheter-related right atrial thrombosis in hemodialysis patients. J Vasc Surg,2018,68(5): 1491–1498. DOI: 10.1016/j.jvs.2018.02.039
|
[13] |
STAVROULOPOULOS A, ARESTI V, ZOUNIS C. Right atrial thrombi complicating haemodialysis catheters. A meta-analysis of reported cases and a proposal of a management algorithm. Nephrol Dial Transplant,2012,27(7): 2936–2744. DOI: 10.1093/ndt/gfr739
|
[14] |
LI Y, GAO Y, GAO Y, et al. Autologous platelet-rich gel treatment for diabetic chronic cutaneous ulcers: a meta-analysis of randomized controlled trials. J Diabetes,2019,11(5): 359–369. DOI: 10.1111/1753-0407.12850
|
[15] |
中华医学会糖尿病学分会, 中华医学会感染病学分会, 中华医学会组织修复与再生分会. 中国糖尿病足防治指南(2019版)(Ⅱ). 中华糖尿病杂志,2019,11(3): 161–189.
|
[16] |
李兰, 冉兴无. 自体富血小板凝胶治疗糖尿病皮肤慢性难愈合创面机制的研究进展. 感染、炎症、修复,2012,13(1): 53–55. DOI: 10.3969/j.issn.1672-8521.2012.01.018
|
[17] |
LI L, CHEN D, WANG C, et al. Autologous platelet-rich gel for treatment of diabetic chronic refractory cutaneous ulcers: a prospective, randomized clinical trial. Wound Repair Regen,2015,23(4): 495–505. DOI: 10.1111/wrr.12294
|
[18] |
孙世怡, 马婧, 冉兴无. β受体阻滞剂治疗创面的作用机制及在糖尿病足溃疡中的应用前景. 中国修复重建外科杂志, 2020[2020-03-12]. https://doi.org/10.7507/1002-1892.202002063.
|
[19] |
高伟, 冉兴无. 钙化防御: 一个临床医师忽略的病变. 中华内科杂志,2017,56(3): 218–220. DOI: 10.3760/cma.j.issn.0578-1426.2017.03.016
|